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The arginine residue(s) necessary for tetrahydrofo- 
late binding to sheep liver  serine hydroxymethyltrans- 
ferase were located by phenylglyoxal modification. 
The incorporation of [7-’4C]phenylglyoxal indicated 
that 2 arginine residues were modified per  subunit  of 
the enzyme and the modification of these residues was 
prevented by tetrahydrofolate. In  order to locate the 
sites of phenylglyoxal modification, the enzyme was 
reacted in the presence and absence of tetrahydrofolate 
using unlabeled and radioactive phenylglyoxal, respec- 
tively. The labeled phenylglyoxal-treated enzyme was 
digested with trypsin, and the radiolabeled peptides 
were purified by high-performance liquid chromatog- 
raphy on reversed-phase columns. Sequencing the 
tryptic peptides indicated that Arg-269 and Arg-462 
were the sites of phenylglyoxal modification. Neither 
a spectrally discernible 495-nm intermediate (charac- 
teristic of the native enzyme when substrates are 
added)  nor its enhancement  by the addition of tetra- 
hydrofolate, was observed with the phenylglyoxal- 
modified enzyme. There was no enhancement of the 
rate of the exchange of the a-proton of glycine upon 
addition of tetrahydrofolate to the modified enzyme as 
was observed with the native enzyme. These results 
demonstrate the requirement of specific arginine resi- 
dues for the interaction of tetrahydrofolate with sheep 
liver  serine hydroxymethyltransferase. 
Serine hydroxymethyltransferase (SHMT,’ EC 2.1.2.1), a 
pyridoxal 5”phosphate (PLP) protein functions in the gen- 
eration of one-carbon units for a variety of end products. The 
enzyme catalyzes the conversion of serine and  tetrahydrofo- 
late  (HI-folate) to form  glycine and 5,lO-methylene HI-folate. 
In addition, a number of aldolytic cleavage reactions are 
catalyzed by the enzyme, but H4-folate is required only when 
formaldehyde is formed (1, 2). Although the catalytic mech- 
anism of the enzyme has been studied in some detail, the 
amino acids that form the active site have not been clearly 
defined. Chemical modification studies with the sheep, human 
liver, and mung bean enzymes indicated that arginine, histi- 
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dine, and cysteine residues were essential for enzyme activity 
(3-5). These studies did not  pinpoint the specific residues in 
the primary structure which  were essential for activity. 
In  this paper, we report the identification of 2 Arg residues, 
Arg-269 and Arg-462, in the primary structure of the sheep 
liver enzyme  which are involved in binding H,-folate and in 
enzyme catalysis. 
EXPERIMENTAL  PROCEDURES 
Materiats-[7-’4C]Phenylglyoxal (23.1 mCi/mmol) was purchased 
from Amersham International (Bucks, England). [2-3H]Glycine (53.3 
Ci/mmol) was obtained from Du Pont-New England Nuclear Re- 
search Products. Nonradioactive phenylglyoxal (PG), N-tosyl-L- 
phenylalanyl chloromethyl ketone (TPCK)-trypsin, trifluoroacetic 
acid were  from  Sigma. Phenyl isothiocyanate sequencing grade was 
from Pierce Chemical Co. Polyamide sheets were obtained from 
Schleicher & Schuell. High-performance liquid chromatography 
(HPLC) grade acetonitrile was obtained from Spectrochem (Bombay, 
India). H4-Folate was prepared by the method of Hatefi et al. (6). 
HPLC columns: Aquapore RP-300 (4.6 X 250 mm, 7 pm) was from 
Pyeunicam, Cambridge, UK, Spherisorb ODS 2 (4 X 250 mm, 5 pm) 
was from Pharmacia, LKB (Uppsala, Sweden). All other reagents 
were  of the highest grade available from commercial sources. 
Incorporation of 7-p4C/PG-Sheep liver SHMT (5 p ~ )  was incu- 
bated with 4 mM PG (23.1  mCi/mmol) in 50 mM potassium phosphate 
buffer, pH 7.4. The reaction was carried out in the presence or absence 
of 2 mM H4-folate at 37 “C for 1 h. After incubation, a  1-pl aliquot 
was spotted on a glass fiber filter paper disc, dried, and counted to 
determine the input radioactivity. The remaining aliquot was precip- 
itated with 10% trichloroacetic acid. The precipitate was washed 
extensively with 10% trichloroacetic acid followed by ethanol and 
dried. The precipitate was dissolved in 50 pl of formic acid and  the 
radioactivity measured. 
Isolation of the PG-modified Peptides from Sheep Liver SHMT- 
SHMT (5 p ~ )  was incubated at 37 “C for 45 min with 4 mM PG in 
the presence of 2 mM H4-folate. The modified  enzyme  was dialyzed 
against 50 mM potassium phosphate buffer (500 ml X 4) for 6  h to 
remove H4-folate. The enzyme was  modified again with 2 mM [7-14C] 
PG for 1 h at 37 ”C in the absence of HI-folate. The enzyme was 
precipitated with 10% trichloroacetic acid and treated with performic 
acid (7). The conditions for digestion and separation of peptides are 
given  (see the legends to Figs. lA, lB,  and 2). 
Sequencing of the Peptides-Peptide 14 was sequenced by the 
manual 4 - N , N  -dimethyl aminoazobenzene isothiocyanate/phenyl 
isothiocyanate double-coupling method (8, 9). Peptide 11 was se- 
quenced using a gas-phase automated  protein sequenator from Shi- 
madzu, PSQ-1. 
Spectral Studies-All spectra were recorded on a Shimadzu UV- 
240 double-beam spectrophotometer. 
RESULTS 
Stoichiometry of the Modification of Sheep  Liver SHMT by 
[7-l4C]PG”The radioactivity incorporated into  the enzyme 
in  the presence of HI-folate (3.01 X lo4 cpm) was approxi- 
mately 10 times less than  that in its absence (2.2 X lo6 cpm). 
This observation suggested that  the Arg residue(s) were pro- 
tected by H4-folate against modification. The stoichiometry 
of the reaction was calculated by deducting the incorporation 
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of PG in the presence of H4-folate from that in its absence. 
Approximately 4 mol of [7-14C]PG were bound per mol of 
subunit  (Mr 50,000) of SHMT when the enzyme was com- 
pletely inactivated. As in most instances, two molecules of 
PG react with 1 Arg residue (10); this result suggested that 
the modification of 2 Arg residues were essential for complete 
loss of activity. 
Separation of Tryptic Peptides Obtained from Control and 
PG-modified SHMT-The profiles of peptides from the con- 
trol and PG-modified enzymes are shown in Fig. 1. The 
estimation of radioactivity in each fraction allowed the iden- 
tification of two radiolabeled peaks (numbered 11, 14) in  the 
PG-modified enzyme profile but  absent  in  the control unmod- 
ified enzyme. This is because Arg  modified  by PG in  proteins 
is known to be resistant to tryptic cleavage (10). Further 
resolution of the two peptides was achieved by rechromatog- 
raphy of these peptides on spherisorb 2 ODS column. The 
HPLC profiles of peaks 11 and  14 upon rechromatography 
are given in Fig. 2. 
Sequencing of Peptides-The thin-layer chromatography 
plates of the 4-N,N”dimethylaminoazobenzene thiohydan- 
toin derivatives (DABTH) of the peptide sequenced manually 
are given in Fig. 3. The sequence obtained was A-G-M-I-F- 
FIG. 1. A,  the elution  profile of the  tryptic peptides from unmod- 
ified sheep liver SHMT. Unmodified sheep liver SHMT (400 pg) was 
hydrolyzed with TPCK-treated trypsin a t  a ratio of 1:lOO (pro- 
tease:protein) in 0.1 M NHIHCOl for 4 h a t  37 “C. The digest was 
lyophilized, dissolved in 0.1% trifluoroacetic acid in water (solvent 
A), and subjected to HPLC using Shimadzu LC-6A. The tryptic 
peptides were initially separated on an Aquapore RP-300 column, 
and  the absorbance of the  eluate monitored a t  225 nm. The peptides 
were eluted with increasing concentrations of 0.1% trifluoroacetic 
acid in  acetonitrile  (solvent  B) as follows: 0-5 min, 0% solvent B; 5- 
60 min, 55% solvent B. The flow rate was 0.5 ml/min. B, the elution 
profile of the  tryptic peptides  from the PG-modified SHMT.  Sheep 
liver SHMT (400 pg) was modified with 4 mM [7-I4C]PG as described 
under “Experimental Procedures.” The tryptic  peptides were sepa- 
rated as described in A.  An aliquot (100 pl) of each fraction was 
dissolved in aqueous scintillation fluid, and the radioactivity was 
measured  in LKB Rackbeta scintillation counter. The bars indicate 
the radioactivity incorporated in each fraction. In order to obtain 
peptide 14 ( B )  in sufficient amounts for manual sequencing, sheep 
liver SHMT (10 mg in 10 ml) was modified with  unlabeled PG  and 
digested  with TPCK-treated  trypsin  as described above. Before frac- 
tionating  the digest, a small  aliquot (5000 cpm) of the labeled peptide 
(peak 14, B )  was added as a  tracer. As peak 11 ( B )  was  sequenced 
using  the PSQ-1 automated sequenator. The  amounts required were 
small, and hence, large-scale  digestion of the enzyme was not carried 
out. 
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FIG. 2. Purification of the radioactive peptides. The  tryptic 
peptides 11 and 14 from Fig. 1B were rechromatographed ( A  and B )  
on  Spherisorb ODS 2 with 0.1% trifluoroacetic acid in  water  (solvent 
A) and 0.1% trifluoroacetic acid in acetonitrile (solvent B) on a 
Shimadzu LC-6A system. The gradients used are indicated. The 
asterisk marks  the peptides carrying radioactivity. The fraction con- 
taining radioactivity was collected for sequencing. 
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FIG. 3. Thin-layer chromatography of DABTH-amino acid 
derivatives from the radioactive peptide 14-6 (Fig. 2). The 
DABTH-amino acids were identified by thin-layer chromatography 
on polyamide sheets (3 X 3 cm) using acetic acid:water (1:2) in the 
first direction and toluene:n-hexane:acetic acid (2:l:O.g) in the second 
dimension. The  spots were located by exposure to HCl vapors. The 
DABTH-amino acid  derivatives are denoted by the single-letter  code; 
U, thiourea derivative; e, DABTC-diethylamine reference marker. 
DABTH-homoserine (obtained from methionine during performic 
acid oxidation) overlapped with DABTH-glutamine in two-dimen- 
sional  chromatography. 
Y-R-K, in which DABTH-modified Arg showed a mobility 
different from other DABTH derivatives. The carryover from 
the previous cycle to  the next cycle of manual sequencing was 
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TABLE I 
Yields of phenylthiohydantoin-amino acids from peptide 11-7 
Cycle Amino acid Yield 
pmol 
1 A 296 
2 V 232 
3 R 
4 A 198 
5 L 172 
6  R 53 
minimal. The presence of Arg was confirmed by automated 
sequencing of a 4-kDa cyanogen bromide fragment  obtained 
during  the course of the primary structure  determination of 
the sheep liver enzyme.' Automated sequencing of peptide 11- 
7 revealed the sequence A-V-X-A-L-R. The Arg at  the third 
position (X represents any amino acid) was conspicuously 
missing from the third cycle of sequencing (Table I). The 
presence of Arg in the third cycle was confirmed by the 
sequence of a chymotryptic fragment obtained  during primary 
structure  determination.  Both the sequences determined con- 
tained  an Arg residue not cleaved by trypsin, an additional 
evidence indicating that  the residue was indeed modified. 
Spectral Studies-Earlier studies (1, 11, 12) with cytosolic 
SHMT suggested the following mechanism for the enzyme 
reaction: (a)  the formation of a geminal diamine followed  by; 
(b)  the generation of a  substrate coenzyme Schiff base; and 
(c) abstraction of the  a-proton of the amino acid to form a 
resonance stabilized quinonoid complex. In the absence of 
H4-folate, the concentration of the quinonoid complex was 
small, while the geminal diamine and Schiff base were present 
in higher amounts. The addition of H4-folate shifted the 
distribution of the complexes with the quinonoid intermediate 
being the dominant species. The spectrum of the native 
enzyme (curue 1) and the three distinct absorption peaks 
obtained on the addition of glycine (200 mM) to  the holoen- 
zyme (curve 2 )  are shown in Fig. 4. The addition of H4-folate 
to  the mixture of enzyme and glycine greatly increased the 
concentration of the quinonoid intermediate absorbing at 495 
nm (curve 3). Fig. 4  (inset) shows the spectrum of the  PG- 
modified enzyme (curue 4 ) .  There was a broadening of the 
characteristic 428-nm PLP-Schiff base absorbance and a  shift 
to 390 nm. Upon addition of saturating  amounts of glycine to 
the PG-modified enzyme only two species were observed the 
geminal diamine at 343 nm and  the glycine Schiff base at 425 
nm (curue 5).  The 495-nm species was not discernible in  the 
spectrum. Upon addition of H4-folate (curue 6), increase in 
the absorbance of the 495-nm species was not observed. All 
the spectral  studies were carried out at  pH 7.4 and 8.3 but 
data  at  pH 7.4 only are given. 
Spectral Studies with Methoxyamine and Thiosemicarba- 
de-Both methoxyamine (13) and thiosemicarbazide were 
shown to inhibit sheep liver SHMT by interacting with PLP 
at  the active site of the enzyme. Fig. 5 (curue 1) represents 
the spectrum of the native enzyme. The spectrum obtained 
on the addition of methoxyamine (100 p ~ )  to the native 
enzyme is shown in Fig. 5 (curve 2 ) .  Methoxyamine formed a 
characteristic 388-nm species in  a  fast  phase of interaction 
with the enzyme. The PG-modified enzyme (curve 3 )  also 
interacted with methoxyamine to form the 388-nm interme- 
diate  as shown in Fig. 5 (curue 4) .3  Thiosemicarbazide inter- 
acted with PLP  at  the active site of sheep liver SHMT  to 
form an enzyme-bound intermediate with absorption maxima 
at 464 and 440 nm (Fig. 5, curue 5). The PG-modified enzyme 
R. Usha and N. Appaji Rao, unpublished data. 
J. K. Acharya and N. Appaji Rao, unpublished data. 
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FIG. 4. Interaction of unmodified enzyme with  glycine and 
H,-folate. The enzyme (5 PM) in 50 mM potassium phosphate buffer, 
pH 7.4, containing 1 mM EDTA, 1 mM 0-mercaptoethanol was 
centrifuged, and  the spectrum of the clear supernatant was recorded 
(curve I ) .  Curve 2 represents the spectrum of the enzyme upon 
addition of 200 mM glycine. Curve 3 is the spectrum obtained upon 
adding 120 PM H,-folate to  the enzyme-glycine mixture (curve 2). 
Inset, the interaction of modified enzyme with glycine and H4-folate. 
The enzyme (2.5 PM)  in 50 mM potassium phosphate buffer, pH 7.4, 
was  modified with 4 mM PG at room temperature for 1 h. The enzyme 
was centrifuged and  the spectrum of the clear supernatant recorded 
(curve 4 ) .  The reference cuvette contained 4 mM PG in buffer. To 
the sample cuvette containing the modified enzyme, 200 mM glycine 
was added and  the spectrum recorded (curve 5). Curve 6 shows the 
spectrum upon addition of H4-folate (120 PM) to the modified enzyme- 
glycine mixture (curve 5). 
5 
WAVELENGTH (nm) 
FIG. 5. The interaction of the unmodified and the PG-mod- 
ified enzymes with methoxyamine and thiosemicarbazide. 
Curve 1 represents the spectrum of the native enzyme (5  pM) in 50 
mM potassium phosphate buffer. Curve 2 represents the spectrum 
upon the addition of methoxyamine 100 PM to the native enzyme. 
Curve 3 represents the spectrum of the PG-modified enzyme. Curve 
4 shows the spectrum of the PG-modified enzyme upon addition of 
100 PM methoxyamine. Curve 5 is the spectrum of the native enzyme 
with thiosemicarbazide (200 FM)? Curve 6 is the spectrum of the PG- 
modified enzyme with thiosemicarbazide (2.2 mM). 
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also interacted with thiosemicarbazide (2.2 mM) to form the 
intermediate (Fig.  5, curue 6). 
Tritium Exchange Studies-A  key step in the mechanism 
of reaction of SHMT with glycine as  the  substrate was the 
removal of the Pro 2 S proton by a base on the enzyme during 
the conversion of the Schiff base to  the quinonoid interme- 
diate. The  rate of exchange of the  a-proton of glycine with 
the solvent protons  and  its increase on addition of H4-folate 
could be correlated with the concentration of the quinonoid 
complex (12). Table I1 shows the results of the  tritium ex- 
change studies with the control and PG-modified enzymes. 
There was a small amount of exchange (462 cpm, Table 11) of 
the a-hydrogen of glycine with the solvent protons in the case 
of the control enzyme. The  rate of this exchange reaction was 
enhanced 200-fold (from 462 to 94,232 cpm, Table 11) on  the 
addition of H4-folate. The  a-proton exchange was  negligible 
(60 cpm) with the PG-modified enzyme, and there was no 
enhancement (100 cpm) of the exchange rate upon addition 
of H4-folate. The exchange experiments were in agreement 
with the fact that  the PG-modified enzyme did not show a 
spectrally discernible quinonoid intermediate,  and  there was 
no increase in its  amount on the addition of H4-folate. 
DISCUSSION 
The involvement of Arg residues in  the catalytic function 
of sheep liver SHMT was indicated by the inactivation of the 
enzyme by PG, a specific Arg-modifying reagent (3). The 
kinetic evidence presented earlier indicated that  at least 1 
residue was necessary for catalysis and that  the positively 
charged guanidinium side chain of  Arg was probably involved 
in binding the carboxyl groups of the  substrate amino acids 
and HI-folate. However, the role of  Arg in catalysis and  its 
position in the primary structure was not established. Hence 
i t  was necessary to isolate the peptides containing the modi- 
fied arginine residues, determine their sequence and place 
them in the primary structure. 
Stoichiometric studies with [7-14C]PG suggested that  the 
Arg residue(s) that were interacting with H4-folate were prob- 
ably modified with PG and  that 2 Arg residues were probably 
modified per  subunit of the enzyme.  Amino acid composition 
of the modified  enzyme indicated that only 2 Arg and no other 
residues were  modified  by PG under the experimental condi- 
tions used.' The sequences of the peptides containing the 
modified Arg residues were A-G-M-I-F-Y-R-K  and A-V-R-A- 
L-R. In view of the extensive homology between the sheep 
and rabbit liver sequences, the modified  Arg residues would 
TABLE I1 
Proton exchange catalyzed by native and modified SHMT 
To sheep liver SHMT (2.5 pM) in HEPES buffer,  pH 7.4, 7.5 mM 
[2-3H]glycine (2 X 10' cpm) was  added and incubated at 37 'C for 30 
min.  The reaction was stopped by the addition of 10% trichloroacetic 
acid. The denatured protein was  removed by centrifugation, and the 
supernatant was  loaded onto a Dowex 50-W 12 column packed in a 
1-ml syringe. The column was washed with 10  ml  of 0.01 M HCl, the 
eluate containing the exchanged 3H was collected, and the radioactiv- 
ity was  measured.  In a second experiment, an identical reaction was 
carried out in the presence of H4-folate (2 mM)  for 1 min. Sheep liver 
SHMT (2.5 p M )  was mixed with 4 mM PG in  0.1 M HEPES buffer, 
pH 7.4, and incubated at 37 'C for 1 h. The modified enzyme was 
assayed for a-proton exchange form [2-3H]glycine as described above. 
Enzyme Addition cpm 
Unmodified 462 
Unmodified H4-folate 94,232 
PG-modified 60 
PG-modified H,-folate 100 
correspond to Arg-269 and Arg-462 in the rabbit liver enzyme 
sequence. 
H4-Folate has a unique role in  the transfer of the hydroxy- 
methyl group from serine. In  all  other reactions catalyzed by 
SHMT such as decarboxylation of amino malonate (14) and 
transamination of alanine (15) H4-folate had no effect on the 
reaction rate. Earlier studies with the rabbit liver enzyme 
showed that serine was  cleaved  by the enzyme in the absence 
of H4-folate, but the formaldehyde dissociated very slowly 
from the active site (11). Therefore a role for H4-folate in the 
serine reaction was postulated, namely, to catalyze the re- 
moval of formaldehyde as 5,lO-methylene H4-folate. It could 
be postulated that if H4-folate  interaction with the enzyme 
was hindered, the earlier steps in the catalysis could be 
unaffected, but  the later  events might not occur. The  inter- 
action of the putative Arg residues with H4-folate can be 
characterized by monitoring the spectral change of the qui- 
nonoid intermediate and the a-proton exchange. The data 
presented in Fig. 4 show that there is no characteristic ab- 
sorbance at 495 nm but the spectra of the geminal diamine 
and  the Schiff base, which are  the early events in catalysis 
are essentially unaffected. The proton exchange was enhanced 
by H4-folate in the control unmodified enzyme, whereas in 
the PG-modified enzyme there was no such increase (Table 
11). These observations clearly point  out that  the Arg resi- 
due(s) identified in this study are probably involved in H4- 
folate interaction,  a  later  event in catalysis, while the earlier 
reactions are probably unaffected. 
In order to examine this possibility, the interaction of PLP 
with the inhibitors was studied. We had earlier demonstrated 
that hydroxylamine derivatives of the substrates such as 
methoxyamine, 0-amino-D-serine, and aminooxyacetate in- 
teract with PLP  at  the active site of SHMT and generate 
characteristic  intermediates  (13,16,17). The formation of the 
characteristic  intermediates on interaction of the PG-modi- 
fied and  the native enzymes indicated that  the interaction of 
PLP with the substrates (Fig. 4) or analogues was probably 
unaffected (Fig. 5). 
In most PLP-dependent enzymes, the positively charged 
guanidinium side chain of  Arg has been implicated in binding 
the phosphate ester of PLP, as in serine dehydratase (EC 
4.2.1.14) PMP oxidase (EC 1.4.3.5) (18, 19). A situation  anal- 
ogous to that seen in PG-modified SHMT was noticed in 
tryptophanase  (EC 4.1.99.1), a  PLP-dependent enzyme which 
catalyzes a @-elimination reaction. Tryptophanase modified 
with PG did not show the 500-nm absorption band  character- 
istic of the native enzyme when substrates are added (20). 
SHMT, in addition to being a PLP enzyme  is a  constituent 
of the thymidylate cycle along with dihydrofolate reductase 
(EC 1.5.1.3) and thymidylate synthase (EC 2.1.1.45) (21). 
Recent site-directed mutagenesis of Arg-70 of human dihy- 
drofolate reductase to Lys revealed that  the  mutant enzyme 
was unable to bind  methotrexate,  the a-carboxyl which inter- 
acted with Arg-70 (22). In thymidylate synthase, labeling with 
['4C]pteroylheptaglutamate indicated that  the analogue was 
covalently attached to Lys-58 of one subunit  and Lys-50 and 
Lys-51 of the other  subunit (23). 
The most facile conclusion and one that is supported by 
our  results  is that  the Arg residues are involved in the binding 
of H4-folate. Since H4-folate exists as  a polyglutamate (24)  it 
is not unreasonable to assume that 2 Arg residues would play 
a role in binding and  orientation of H4-folate at  the active 
site. An Arg-carboxylate interaction might be preferred over 
simple charge interactions since the guanidinium group would 
present charged hydrogen bonds to  the carboxylate substrate 
rather  than  the single bond formed by lysine- or histidine- 
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TABLE 111 
Comparison of sequences around Arg-269 and Arg-462 in sheep liver 
and other SHMTs 
Top part: positions of the amino acid residues aligned are  as follows. 
E. coli enzyme, residues 232-241 (27); rabbit cytosolic enzyme, resi- 
dues 259-274 (25), rabbit mitochondrial enzyme, residues 254-269 
(26); and sheep liver  enzyme sequence.2 Bottom part: positions of the 
amino acid residues aligned are as follows. E. coli enzyme, residues 
402-415 (27); rabbit cytosolic enzyme, residues 452-465 (25); rabbit 
mitochondrial enzyme, residues 444-457 (26); and the sheep liver 
enzyme sequence? 
The conserved residues are boxed  by the solid  line. 
Sheep SHMT 
Rabbit cytosolic SHMT 
Rabbit mitochondrial SHMT 
E. coli SHMT 
Sheep SHMT A G A E E H Q R A V R A L R  r-l 
Rabbit cytosolic SHMT 
Rabbit mitochondrial SHMT 
E. coli SHMT A K E L A G W M C D S I N D  
carboxylate interactions.  Table I11 shows the sequences flank- 
ing the Arg residues in  the sheep liver, the rabbit liver cyto- 
solic and mitochondrial protein sequences (25, 26), and  the 
deduced amino acid sequence of the Escherichia coli enzyme 
(27). Both the Arg residues identified in the sheep liver 
sequence are well conserved in the rabbit liver cytosolic en- 
zyme sequence, but  there  is no apparent local sequence ho- 
mology in the E. coli enzyme. Detailed investigations are in 
progress with the PG-modified E. coli e n ~ y m e . ~  
The  data reported herein show that Arg residues are  present 
at the active site of the sheep liver enzyme.  We have localized 
these residues to  short stretches of the primary sequence. The 
data suggest that these residues are involved in binding H4- 
folate. Further  studies designed to test  the role of other amino 
acid residues in the sheep liver enzyme which are  important 
for catalysis should help in defining the architecture of the 
active site of the enzyme. 
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